Blinatumomab-associated vasculitis - Wikidata - wikimedia - TriplyDB

Blinatumomab-associated vasculitis

Blinatumomab-associated vasculitis

http://www.wikidata.org/entity/Q41597386

about

Blinatumomab-associated vasculitis

http://www.wikidata.org/entity/Q41597386

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Blinatumomab-associated vasculitis

@en

type

label

Blinatumomab-associated vasculitis

@en

prefLabel

Blinatumomab-associated vasculitis

@en

P1433

Q41597386-3A87E52A-44F5-4AFC-A8FA-CFAAD9DBEA14

P1476

Q41597386-F1A03FCF-E1C0-4327-8910-11E2A8659D5F

P2093

Q41597386-3BD94A0B-1EE2-4EF4-B2A7-BB43B0542F7F

Q41597386-A42B4A8D-A027-470A-A06A-ABC7EE3A3B9B

Q41597386-D6922882-4D82-432B-A2DD-0B3F9A1A6B5F

Q41597386-F5748507-81F8-4512-A741-58BC3574DA2F

P2860

Q41597386-0499669A-C7E1-4205-8952-13120861EB10

Q41597386-3D0BEEBE-E3E5-4F3D-BC37-653B889A50E4

Q41597386-53716B0A-F72D-4BA2-A9CB-96E253124636

Q41597386-F02F9B3F-F074-4EDE-8215-F2BD7107C349

P304

Q41597386-40A1A528-0CD2-4511-BA43-C439F39ECFA1

P31

Q41597386-0B0C9F4A-1648-456F-9515-98A345D7F895

Q41597386-9ede50cf-16bb-48f0-af05-fedf16655db9

P356

Q41597386-A5B804A8-B9F6-41E7-8D2B-8703B2631664

P433

Q41597386-80DD8B27-5A66-491B-8F49-D597BF62A54A

P478

Q41597386-984600F8-D59B-447D-A285-673DE0E5161A

P577

Q41597386-4885C88C-19E8-400E-8DCF-B0D8720A5150

P698

Q41597386-E435DCB2-7EED-47B0-AC61-2CF81CA89088

P932

Q41597386-86FF7674-81E5-4030-9BAC-792B3FA6317E

P356

J.JDCR.2017.01.017

P1433

JAAD case reports

P1476

Blinatumomab-associated vasculitis

@en

P2093

Huma Jaffar

http://www.w3.org/2001/XMLSchema#string

Jingxiang Huang

http://www.w3.org/2001/XMLSchema#string

MeiQi May Liau

http://www.w3.org/2001/XMLSchema#string

Valencia Long

http://www.w3.org/2001/XMLSchema#string

P2860

Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Blinatumomab: a historical perspective.

Blinatumomab for the treatment of B-cell lymphoma.

P304

395-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JDCR.2017.01.017

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28879223

http://www.w3.org/2001/XMLSchema#string

P932

5581850

http://www.w3.org/2001/XMLSchema#string